SlideShare una empresa de Scribd logo
1 de 4
Descargar para leer sin conexión
Monday, July 23, 2012 3:02 PM


Subject: IWCC Proposed Rules For Drug Testing
Date: Monday, July 23, 2012 2:31 PM Jul 23
From: Joe Garofalo <jgarofalo@gshslaw.com>
To: bhart@gshslaw.com
Conversation: IWCC Proposed Rules For Drug Testing

Dear Friends,

The Illinois Workers' Compensation Commission has finally published a proposed Rule governing the
collection and testing of samples for alcohol and other drugs that may form the basis for an employer’s
defense to a claim for workers’ compensation benefits due to an employee’s intoxication. The Commission
will be taking comments on this proposed Rule through July 30, 2012.

Matt Novak has prepared a wonderful synopsis of the proposed Rule which is contained below. As you will
see from his article, strict compliance with the Rule will be necessary in order to introduce the results of
alcohol and drug testing into evidence. In light of the onerous requirements to admit such evidence we
recommend that most employers NOT engage in the alcohol and drug collection process themselves but
instead contract with outside firms who are already engaged in this process as their main business and who
are in compliance with these requirements. For those employers who are already performing such testing and
intend to continue to do so on site, please note that it will be essential to comply with the rules for collection
or testing or else the test results will not be admissible in evidence.

Please feel free to contact us with any questions or comments you may have regarding this matter.
Sincerely yours,


Joe Garofalo


                                COMMISSION PROPOSES RULES FOR DRUG TESTING

As many of our readers may know, the most recent amendments to the Illinois Workers’ Compensation Act amend Section
11 to establish an employee’s intoxication as a potential defense against liability for injuries sustained in a work accident.
This amendment, which became effective June 28, 2011, charged the Illinois Workers’ Compensation Commission (the
“Commission”) with developing rules for sample collection and testing for alcohol and other drugs that could be considered
intoxicating substances. On June 15, 2012 the Commission published its proposed rules governing the collection and
testing of samples for alcohol and other drugs. Please note that there is a comment period during which time interested
parties can provide their thoughts or opinions on the proposed rules, which closes forty-five days after the date of
publication, or July 30, 2012. Interested parties should contact Kimberly B. Janas, the Secretary of the Commission, with
their comments before the close of time period. Her information is as follows:

                                        Illinois Workers’ Compensation Commission

                                          100 West Randolph Street, Suite 8-200

                                                  Chicago, Illinois 60601

                                                    PH: (312) 814-6559

                                                   FAX: (312) 814-3520

                                                    k.janas@illinois.gov
                                                                                                                  Page 1 of 4
k.janas@illinois.gov

The proposed rules are thirty-one pages in length, and cover in detail the process and procedure of collecting different
types of specimens and conducting tests to establish intoxication by alcohol or other substances. What follows is a brief
summary of the proposed rules and some of the possible ways it may affect administering and defending workers’
compensation claims in Illinois.

CHAIN OF CUSTODY FORM

After a section outlining the definitions of various terms used in the proposed rules, Proposed Rule 9140.10 creates a
“Chain of Custody Form” to be used in the collection of blood and urine specimens. It is not indicated whether the
Commission will publish this Chain of Custody Form, or if employers, insurance carriers or medical providers will need to
develop and publish their own forms independently. This rule indicates the Chain of Custody Form must have four
sections, with each section having specific informational requirements to be completed by the various parties participating
in the specimen collection and testing process. The rule also provides that there needs to be seven copies of the Form,
and that the parties involved in the collection and testing process must keep a copy of the Form for a minimum of two
years. The rule specifically states that the Chain of Custody Form must include all of the information specified within the
rule. This is a mandatory requirement, and the use of any non-complying form, or the failure of a party to properly complete
a form, could result in the test results being excluded from evidence at trial. While the use of a non-complying Form should
not be an issue of the Commission creates and provides a Chain of Custody Form for parties to utilize, the use of a privately
created form could cause issues by failing to comply with the rule.

COLLECTION OF BLOOD AND URINE SAMPLES

Proposed Rules 9140.20 and 9140.30 govern the collection procedures for specimens of blood and urine, respectively.
Only certain medical personnel, such as a licensed physician or a registered nurse, are allowed perform the collection of
blood specimens under the rules. Urine collection can be done not only by certain medical personnel, but also by a person
meeting the training requirements of United States Department of Transportation’s training requirements as specified in the
Code of Federal Regulations (49 CFR 40.33). It is conceivable that an employee of the employer could meet these training
requirements and serve as a urine collector, and the rules contemplate this possibility by specifically excluding an
employee’s immediate supervisor from being the collector, unless no other collector is available. The Rules establishing the
process for collecting urine specimens are so lengthy and detailed, taking up over six pages or the rules themselves, that
we believe it highly impractical for an employer to conduct urine collections onsite and with its own employees. Rather, we
believe employers would be best served having a designated clinic or other facility conduct its both blood and urine
collections, provided those facilities conform to the Commission’s rules. Otherwise, any failure to follow the requirements of
the rules in the collection process may render a positive drug test result inadmissible, making an intoxication defense
impossible.

MEDICAL REVIEW OFFICERS

Rule 9140.40 creates the process of review and verification of test results by a medical review officer (MRO). An MRO is
defined as the person meeting the qualifications set forth in the Code of Federal Regulations, 49 CFR 40.121, and cannot
be employed by the laboratory performing the testing of the relevant samples. Furthermore, an employer or a designated
employer representative cannot serve as the MRO for his or her own employees. All test results must be sent from the
laboratory to an MRO to be reviewed and verified. When the MRO receives a positive, adulterated or a substituted result
from the laboratory, the MRO is required to contact the employee within seventy-two hours of receiving the test result. The
purpose of contacting the employee is to create an opportunity for the employee to provide information that the he or she
considers relevant to explain a positive, substituted or adulterated test result. For example, an employee may identify for
the MRO the use of certain prescription or non-prescription medications that could have influenced the test result. If the
MRO is unable to contact the employee to discuss the positive, adulterated or substituted test results, it becomes the duty
of the designated employer representative to contact the employee to have him or her contact the MRI as soon as
possible. There is no information provided as to what happens if the employee fails to contact the MRO altogether, but it
would appear that the MRO is free to verify the test results without input from the employee, and to transmit that evidence to
the employer or the designated employer representative after the seventy-two hour contact period has lapsed.

The MRO is charged with taking various steps to verify the testing results, taking particular care when the lab reports a
positive, adulterated or substituted test result. The MRO is also charged with verifying and forwarding negative test results
to the parties.

SPLIT TESTING OF URINE AND BLOOD SPECIMENS

Proposed Rule 9140.50 sets up the procedures for split testing. When an employee has a positive, adulterated or
substituted result from the laboratory, he or she may provide a written or verbal request to the MRO to have a split
                                                                                                                  Page 2 of 4
substituted result from the laboratory, he or she may provide a written or verbal request to the MRO to have a split
specimen undergo testing procedures. The rule states that this request must be provided within seventy-two hours or
receiving notification of a positive, adulterated or substituted test result from the MRO, unless the employee can provide a
legitimate reason for his or her failure to contact the MRO within seventy-two hours.

The rule specifically states that the employer shall ensure the split specimen testing is conducted as required, which we
take to mean the employer must guaranty payment to the second laboratory for the cost of testing the split specimen. An
employer may, however, seek repayment or reimbursement of all or part of the cost of the split specimen testing from the
employee, though an employer cannot condition performance of the split testing upon he employee’s payment of the costs
associated with the test. In the likely event that an employee refuses to pay or reimburse the employer for the costs of split
testing, perhaps the employer could claim a credit to offset the payment of benefits in an amount equal to the cost of split
testing, should the case proceed to trial.

COLLECTION AND TESTING OF BREATH AND SALIVA FOR ALCOHOL TESTING

Rule 9140.60 outlines the process of procedures of conducting testing for alcohol through both breath and saliva. The rule
states that collectors for alcohol testing must meet the training requirements set forth in 49 CFR 40.213. Again, these rules
contemplate that an employee of the employer could serve as a collector for alcohol testing.

It is important to note that any collection method used by law enforcement officers is to be considered acceptable procedure
for the collection of testing of breath and alcohol under these other proposed rules. It does state that any collection of
breath or testing or performed by a law enforcement officer is subject to any objection pursuant to the Illinois Rules of
Evidence and statutory rules of evidence where applicable.

Alcohol testing must also be documented using a collection form, different than the Chain of Custody Form, and the rules
specify what information must be documented in the collection form. Similar to other collection methods, the collection
procedures for breath and saliva when testing for alcohol are specific and detailed, and the rules state that all of the
process and procedures must be complied with. Beyond having to obtain and maintain conforming testing equipment, the
testing technician must ensure that each test is conducted in accordance with the specific procedure outlined by the rules.
Therefore, unless an employer has unique or extenuating circumstances requiring immediate onsite testing, we would not
recommend an employer take upon itself the job of conducting breath or saliva testing of its employees for alcohol. We
believe it would be better to allocate the testing process to professionals who conduct this testing process on a regular
basis to ensure that all the requirements of the rules are met, and to ensure that the positive test result is admissible at
hearing. Should an employer decide to engage in alcohol testing through breath or saliva analysis, careful review of the
referenced Code of Federal Regulations, as well as the Commission Rules, will be necessary in order to ensure compliance
with the testing procedures used.

PRESERVATION OF SPECIMENS AND RECORDS

Proposed Rule 9140.70 specifies the length of time the parties must keep either specimens or records associated with drug
testing. Laboratories testing the primary specimen of blood or urine with appositive, adulterated or substantive result must
retain the specimen for a minimum of three years, and it must be stored in a manner as outlined in the rules and in
accordance with the requirements set forth by the Department of Health and Human Services (though not specified, it
appears the rule is referring to the Federal agency). An employee, the MRO, or the employer may request, in writing, that
the laboratory retain a specimen for an additional period of time not to exceed one year. Split specimens must also be
retained in a similar fashion. Laboratories must retain all records pertaining to the testing of each employee specimen for a
minimum of two years, though this can be extended through a written request for an additional two years. Employers are
required to maintain all collection forms for breath and saliva testing for a minimum of three years, and the employee may
request an extension of up to an additional year. Negative testing samples are to be discarded as soon as possible.

CONCLUSION

Many employers conduct routine drug testing anytime an employee reports a workers’ compensation injury. For those
employers, we recommend confirming with your drug testing vendors to confirm whether the procedures to have in place
will comply with proposed rules to ensure a timely and effective transition for defending injuries resulting from alcohol or
drug intoxication. As it seems that the Commission borrowed from the Code of Federal Regulations when drafting these
proposed rules on the process and procedure of specimen collection and drug testing, it is possible that most facilities
currently providing specimen collection or drug testing will already be in compliance with these proposed rules.
Nevertheless, any facility must be prepared to confirm that it wholly complies with the proposed rules, as even substantial
compliance with the rules may still result in a positive drug test result being barred from evidence. This is due to the fact
that the rules use mandatory terms like “shall” and “must” throughout.

For those employers who do not perform routine drug testing at the time an accident is reported, we would recommend
                                                                                                                  Page 3 of 4
For those employers who do not perform routine drug testing at the time an accident is reported, we would recommend
identifying a facility or vendor that complies with the proposed rules to which an employee suspected of intoxication can be
referred for appropriate sample collection and testing. Even if it is clear by circumstantial evidence that an employee’s
accident was caused by his or her intoxication, a failure to properly preserve this evidence through a conforming collection
and testing process could result in an inability to deny the claim. By having an appropriate facility identified in advance, the
chances of successfully obtaining an admissible test result and defending a claim could increase significantly.

Should you have any questions or concerns regarding these proposed comments, please feel free to contact any of the
attorneys in our office to discuss them in greater detail. We look forward to an open ongoing dialog with our clients as this
new statutory defense in intoxication continues to develop.

--

Joseph A. Garofalo

Garofalo, Schreiber, Hart & Storm, Chartered
55 West Wacker Drive, 10th Floor
Chicago, IL 60601

Office: 312-670-2000
Direct: 312-499-8911
Cell: 312-622-3750
Fax: 312-419-1336
jgarofalo@gshslaw.com

www.gshslaw.com

Celebrating our 28th year in business

This is an advertisement and is being sent to you because of your prior relationship with the firm of Garofalo, Schreiber,
Hart & Storm, Chartered.

To unscribe click here: Unsubscribe

     This is an advertisement and is being sent to you because of your prior relationship
                 with the firm of Garofalo, Schreiber, Hart & Storm, Chartered.




                                                                                                                    Page 4 of 4

Más contenido relacionado

Destacado

Laboratory and diagnostic examination
Laboratory and diagnostic examinationLaboratory and diagnostic examination
Laboratory and diagnostic examinationNursing Path
 
Drug testing powerpoint
Drug testing powerpointDrug testing powerpoint
Drug testing powerpointMegan12108
 
Revised dangerous drug act
Revised dangerous drug actRevised dangerous drug act
Revised dangerous drug actMarvie JOiz Ante
 
Dangerous Drug Act of 2012
Dangerous Drug Act of 2012Dangerous Drug Act of 2012
Dangerous Drug Act of 2012Diane Infante
 
Blood collection and preservation
Blood collection  and preservationBlood collection  and preservation
Blood collection and preservationglobalsoin
 
NurseReview.Org Common Laboratory Procedures
NurseReview.Org Common Laboratory ProceduresNurseReview.Org Common Laboratory Procedures
NurseReview.Org Common Laboratory ProceduresNurse ReviewDotOrg
 
Drugs power point
Drugs power pointDrugs power point
Drugs power pointMATTY_666
 
Drug Awareness Presentation
Drug Awareness PresentationDrug Awareness Presentation
Drug Awareness Presentationdengranai
 

Destacado (9)

Laboratory and diagnostic examination
Laboratory and diagnostic examinationLaboratory and diagnostic examination
Laboratory and diagnostic examination
 
Dangerous drugs ppt
Dangerous drugs pptDangerous drugs ppt
Dangerous drugs ppt
 
Drug testing powerpoint
Drug testing powerpointDrug testing powerpoint
Drug testing powerpoint
 
Revised dangerous drug act
Revised dangerous drug actRevised dangerous drug act
Revised dangerous drug act
 
Dangerous Drug Act of 2012
Dangerous Drug Act of 2012Dangerous Drug Act of 2012
Dangerous Drug Act of 2012
 
Blood collection and preservation
Blood collection  and preservationBlood collection  and preservation
Blood collection and preservation
 
NurseReview.Org Common Laboratory Procedures
NurseReview.Org Common Laboratory ProceduresNurseReview.Org Common Laboratory Procedures
NurseReview.Org Common Laboratory Procedures
 
Drugs power point
Drugs power pointDrugs power point
Drugs power point
 
Drug Awareness Presentation
Drug Awareness PresentationDrug Awareness Presentation
Drug Awareness Presentation
 

Similar a Drug Testing Rules

Patients direct access to lab results
Patients direct access to lab resultsPatients direct access to lab results
Patients direct access to lab resultsViSolve, Inc.
 
Supervisor Drug Awareness and Reasonable Suspicion by P&A Consulting Services
Supervisor Drug Awareness and Reasonable Suspicion by P&A Consulting ServicesSupervisor Drug Awareness and Reasonable Suspicion by P&A Consulting Services
Supervisor Drug Awareness and Reasonable Suspicion by P&A Consulting ServicesAtlantic Training, LLC.
 
Company HSE for WC Welding Services 2014
Company HSE for WC Welding Services 2014Company HSE for WC Welding Services 2014
Company HSE for WC Welding Services 2014Chris Schmidt
 
New flexible working regime in the United Kingdom
New flexible working regime in the United Kingdom New flexible working regime in the United Kingdom
New flexible working regime in the United Kingdom Ius Laboris
 
CENTRAL TESTING LABORATORIES IN INDIA
CENTRAL TESTING LABORATORIES IN INDIACENTRAL TESTING LABORATORIES IN INDIA
CENTRAL TESTING LABORATORIES IN INDIARishabh Sharma
 
Background Checks White Paper
Background Checks White PaperBackground Checks White Paper
Background Checks White Paperpattywise
 
Important-Clauses-in-Clinical-Trial-Agreement.pdf
Important-Clauses-in-Clinical-Trial-Agreement.pdfImportant-Clauses-in-Clinical-Trial-Agreement.pdf
Important-Clauses-in-Clinical-Trial-Agreement.pdfInthumathiGovindasam
 
New Vaccination Rule: What Does it Mean for Employers with More Than 100 Empl...
New Vaccination Rule: What Does it Mean for Employers with More Than 100 Empl...New Vaccination Rule: What Does it Mean for Employers with More Than 100 Empl...
New Vaccination Rule: What Does it Mean for Employers with More Than 100 Empl...Parsons Behle & Latimer
 
NLRB Ambush Elections Have Arrived - Are You Ready Philadelphia
NLRB Ambush Elections Have Arrived - Are You Ready PhiladelphiaNLRB Ambush Elections Have Arrived - Are You Ready Philadelphia
NLRB Ambush Elections Have Arrived - Are You Ready PhiladelphiaThomas Benjamin Huggett
 
HR in Pharma Networking Event - Fiona Coombe
HR in Pharma Networking Event - Fiona Coombe HR in Pharma Networking Event - Fiona Coombe
HR in Pharma Networking Event - Fiona Coombe CK Group
 
Requirement to clinical study
Requirement to clinical studyRequirement to clinical study
Requirement to clinical studyDhanshreeBhattad
 
Medical societies-letter-to-cms
Medical societies-letter-to-cmsMedical societies-letter-to-cms
Medical societies-letter-to-cmsMarket iT
 
New drugs and clinical trial rules 2019.pdf
New drugs and clinical trial rules 2019.pdfNew drugs and clinical trial rules 2019.pdf
New drugs and clinical trial rules 2019.pdfcrazyboy92
 
Oregon Employment Law Update May 2012 (00259821)
Oregon Employment Law Update May 2012 (00259821)Oregon Employment Law Update May 2012 (00259821)
Oregon Employment Law Update May 2012 (00259821)TEllaRussell
 
News Views - Ambush Elections
News  Views - Ambush ElectionsNews  Views - Ambush Elections
News Views - Ambush ElectionsJohn Bowen
 

Similar a Drug Testing Rules (20)

Patients direct access to lab results
Patients direct access to lab resultsPatients direct access to lab results
Patients direct access to lab results
 
463 Laws
463 Laws463 Laws
463 Laws
 
LABOR LAW COMPLIANCE
LABOR LAW COMPLIANCELABOR LAW COMPLIANCE
LABOR LAW COMPLIANCE
 
Supervisor Drug Awareness and Reasonable Suspicion by P&A Consulting Services
Supervisor Drug Awareness and Reasonable Suspicion by P&A Consulting ServicesSupervisor Drug Awareness and Reasonable Suspicion by P&A Consulting Services
Supervisor Drug Awareness and Reasonable Suspicion by P&A Consulting Services
 
Drug Testing by Connecticut DOL
Drug Testing by Connecticut DOLDrug Testing by Connecticut DOL
Drug Testing by Connecticut DOL
 
Fitness for Duty: The ADA and Beyond
Fitness for Duty: The ADA and BeyondFitness for Duty: The ADA and Beyond
Fitness for Duty: The ADA and Beyond
 
Company HSE for WC Welding Services 2014
Company HSE for WC Welding Services 2014Company HSE for WC Welding Services 2014
Company HSE for WC Welding Services 2014
 
New flexible working regime in the United Kingdom
New flexible working regime in the United Kingdom New flexible working regime in the United Kingdom
New flexible working regime in the United Kingdom
 
CENTRAL TESTING LABORATORIES IN INDIA
CENTRAL TESTING LABORATORIES IN INDIACENTRAL TESTING LABORATORIES IN INDIA
CENTRAL TESTING LABORATORIES IN INDIA
 
Background Checks White Paper
Background Checks White PaperBackground Checks White Paper
Background Checks White Paper
 
Important-Clauses-in-Clinical-Trial-Agreement.pdf
Important-Clauses-in-Clinical-Trial-Agreement.pdfImportant-Clauses-in-Clinical-Trial-Agreement.pdf
Important-Clauses-in-Clinical-Trial-Agreement.pdf
 
New Vaccination Rule: What Does it Mean for Employers with More Than 100 Empl...
New Vaccination Rule: What Does it Mean for Employers with More Than 100 Empl...New Vaccination Rule: What Does it Mean for Employers with More Than 100 Empl...
New Vaccination Rule: What Does it Mean for Employers with More Than 100 Empl...
 
NLRB Ambush Elections Have Arrived - Are You Ready Philadelphia
NLRB Ambush Elections Have Arrived - Are You Ready PhiladelphiaNLRB Ambush Elections Have Arrived - Are You Ready Philadelphia
NLRB Ambush Elections Have Arrived - Are You Ready Philadelphia
 
HR in Pharma Networking Event - Fiona Coombe
HR in Pharma Networking Event - Fiona Coombe HR in Pharma Networking Event - Fiona Coombe
HR in Pharma Networking Event - Fiona Coombe
 
Requirement to clinical study
Requirement to clinical studyRequirement to clinical study
Requirement to clinical study
 
Newsletter October Issue
Newsletter October IssueNewsletter October Issue
Newsletter October Issue
 
Medical societies-letter-to-cms
Medical societies-letter-to-cmsMedical societies-letter-to-cms
Medical societies-letter-to-cms
 
New drugs and clinical trial rules 2019.pdf
New drugs and clinical trial rules 2019.pdfNew drugs and clinical trial rules 2019.pdf
New drugs and clinical trial rules 2019.pdf
 
Oregon Employment Law Update May 2012 (00259821)
Oregon Employment Law Update May 2012 (00259821)Oregon Employment Law Update May 2012 (00259821)
Oregon Employment Law Update May 2012 (00259821)
 
News Views - Ambush Elections
News  Views - Ambush ElectionsNews  Views - Ambush Elections
News Views - Ambush Elections
 

Drug Testing Rules

  • 1. Monday, July 23, 2012 3:02 PM Subject: IWCC Proposed Rules For Drug Testing Date: Monday, July 23, 2012 2:31 PM Jul 23 From: Joe Garofalo <jgarofalo@gshslaw.com> To: bhart@gshslaw.com Conversation: IWCC Proposed Rules For Drug Testing Dear Friends, The Illinois Workers' Compensation Commission has finally published a proposed Rule governing the collection and testing of samples for alcohol and other drugs that may form the basis for an employer’s defense to a claim for workers’ compensation benefits due to an employee’s intoxication. The Commission will be taking comments on this proposed Rule through July 30, 2012. Matt Novak has prepared a wonderful synopsis of the proposed Rule which is contained below. As you will see from his article, strict compliance with the Rule will be necessary in order to introduce the results of alcohol and drug testing into evidence. In light of the onerous requirements to admit such evidence we recommend that most employers NOT engage in the alcohol and drug collection process themselves but instead contract with outside firms who are already engaged in this process as their main business and who are in compliance with these requirements. For those employers who are already performing such testing and intend to continue to do so on site, please note that it will be essential to comply with the rules for collection or testing or else the test results will not be admissible in evidence. Please feel free to contact us with any questions or comments you may have regarding this matter. Sincerely yours, Joe Garofalo COMMISSION PROPOSES RULES FOR DRUG TESTING As many of our readers may know, the most recent amendments to the Illinois Workers’ Compensation Act amend Section 11 to establish an employee’s intoxication as a potential defense against liability for injuries sustained in a work accident. This amendment, which became effective June 28, 2011, charged the Illinois Workers’ Compensation Commission (the “Commission”) with developing rules for sample collection and testing for alcohol and other drugs that could be considered intoxicating substances. On June 15, 2012 the Commission published its proposed rules governing the collection and testing of samples for alcohol and other drugs. Please note that there is a comment period during which time interested parties can provide their thoughts or opinions on the proposed rules, which closes forty-five days after the date of publication, or July 30, 2012. Interested parties should contact Kimberly B. Janas, the Secretary of the Commission, with their comments before the close of time period. Her information is as follows: Illinois Workers’ Compensation Commission 100 West Randolph Street, Suite 8-200 Chicago, Illinois 60601 PH: (312) 814-6559 FAX: (312) 814-3520 k.janas@illinois.gov Page 1 of 4
  • 2. k.janas@illinois.gov The proposed rules are thirty-one pages in length, and cover in detail the process and procedure of collecting different types of specimens and conducting tests to establish intoxication by alcohol or other substances. What follows is a brief summary of the proposed rules and some of the possible ways it may affect administering and defending workers’ compensation claims in Illinois. CHAIN OF CUSTODY FORM After a section outlining the definitions of various terms used in the proposed rules, Proposed Rule 9140.10 creates a “Chain of Custody Form” to be used in the collection of blood and urine specimens. It is not indicated whether the Commission will publish this Chain of Custody Form, or if employers, insurance carriers or medical providers will need to develop and publish their own forms independently. This rule indicates the Chain of Custody Form must have four sections, with each section having specific informational requirements to be completed by the various parties participating in the specimen collection and testing process. The rule also provides that there needs to be seven copies of the Form, and that the parties involved in the collection and testing process must keep a copy of the Form for a minimum of two years. The rule specifically states that the Chain of Custody Form must include all of the information specified within the rule. This is a mandatory requirement, and the use of any non-complying form, or the failure of a party to properly complete a form, could result in the test results being excluded from evidence at trial. While the use of a non-complying Form should not be an issue of the Commission creates and provides a Chain of Custody Form for parties to utilize, the use of a privately created form could cause issues by failing to comply with the rule. COLLECTION OF BLOOD AND URINE SAMPLES Proposed Rules 9140.20 and 9140.30 govern the collection procedures for specimens of blood and urine, respectively. Only certain medical personnel, such as a licensed physician or a registered nurse, are allowed perform the collection of blood specimens under the rules. Urine collection can be done not only by certain medical personnel, but also by a person meeting the training requirements of United States Department of Transportation’s training requirements as specified in the Code of Federal Regulations (49 CFR 40.33). It is conceivable that an employee of the employer could meet these training requirements and serve as a urine collector, and the rules contemplate this possibility by specifically excluding an employee’s immediate supervisor from being the collector, unless no other collector is available. The Rules establishing the process for collecting urine specimens are so lengthy and detailed, taking up over six pages or the rules themselves, that we believe it highly impractical for an employer to conduct urine collections onsite and with its own employees. Rather, we believe employers would be best served having a designated clinic or other facility conduct its both blood and urine collections, provided those facilities conform to the Commission’s rules. Otherwise, any failure to follow the requirements of the rules in the collection process may render a positive drug test result inadmissible, making an intoxication defense impossible. MEDICAL REVIEW OFFICERS Rule 9140.40 creates the process of review and verification of test results by a medical review officer (MRO). An MRO is defined as the person meeting the qualifications set forth in the Code of Federal Regulations, 49 CFR 40.121, and cannot be employed by the laboratory performing the testing of the relevant samples. Furthermore, an employer or a designated employer representative cannot serve as the MRO for his or her own employees. All test results must be sent from the laboratory to an MRO to be reviewed and verified. When the MRO receives a positive, adulterated or a substituted result from the laboratory, the MRO is required to contact the employee within seventy-two hours of receiving the test result. The purpose of contacting the employee is to create an opportunity for the employee to provide information that the he or she considers relevant to explain a positive, substituted or adulterated test result. For example, an employee may identify for the MRO the use of certain prescription or non-prescription medications that could have influenced the test result. If the MRO is unable to contact the employee to discuss the positive, adulterated or substituted test results, it becomes the duty of the designated employer representative to contact the employee to have him or her contact the MRI as soon as possible. There is no information provided as to what happens if the employee fails to contact the MRO altogether, but it would appear that the MRO is free to verify the test results without input from the employee, and to transmit that evidence to the employer or the designated employer representative after the seventy-two hour contact period has lapsed. The MRO is charged with taking various steps to verify the testing results, taking particular care when the lab reports a positive, adulterated or substituted test result. The MRO is also charged with verifying and forwarding negative test results to the parties. SPLIT TESTING OF URINE AND BLOOD SPECIMENS Proposed Rule 9140.50 sets up the procedures for split testing. When an employee has a positive, adulterated or substituted result from the laboratory, he or she may provide a written or verbal request to the MRO to have a split Page 2 of 4
  • 3. substituted result from the laboratory, he or she may provide a written or verbal request to the MRO to have a split specimen undergo testing procedures. The rule states that this request must be provided within seventy-two hours or receiving notification of a positive, adulterated or substituted test result from the MRO, unless the employee can provide a legitimate reason for his or her failure to contact the MRO within seventy-two hours. The rule specifically states that the employer shall ensure the split specimen testing is conducted as required, which we take to mean the employer must guaranty payment to the second laboratory for the cost of testing the split specimen. An employer may, however, seek repayment or reimbursement of all or part of the cost of the split specimen testing from the employee, though an employer cannot condition performance of the split testing upon he employee’s payment of the costs associated with the test. In the likely event that an employee refuses to pay or reimburse the employer for the costs of split testing, perhaps the employer could claim a credit to offset the payment of benefits in an amount equal to the cost of split testing, should the case proceed to trial. COLLECTION AND TESTING OF BREATH AND SALIVA FOR ALCOHOL TESTING Rule 9140.60 outlines the process of procedures of conducting testing for alcohol through both breath and saliva. The rule states that collectors for alcohol testing must meet the training requirements set forth in 49 CFR 40.213. Again, these rules contemplate that an employee of the employer could serve as a collector for alcohol testing. It is important to note that any collection method used by law enforcement officers is to be considered acceptable procedure for the collection of testing of breath and alcohol under these other proposed rules. It does state that any collection of breath or testing or performed by a law enforcement officer is subject to any objection pursuant to the Illinois Rules of Evidence and statutory rules of evidence where applicable. Alcohol testing must also be documented using a collection form, different than the Chain of Custody Form, and the rules specify what information must be documented in the collection form. Similar to other collection methods, the collection procedures for breath and saliva when testing for alcohol are specific and detailed, and the rules state that all of the process and procedures must be complied with. Beyond having to obtain and maintain conforming testing equipment, the testing technician must ensure that each test is conducted in accordance with the specific procedure outlined by the rules. Therefore, unless an employer has unique or extenuating circumstances requiring immediate onsite testing, we would not recommend an employer take upon itself the job of conducting breath or saliva testing of its employees for alcohol. We believe it would be better to allocate the testing process to professionals who conduct this testing process on a regular basis to ensure that all the requirements of the rules are met, and to ensure that the positive test result is admissible at hearing. Should an employer decide to engage in alcohol testing through breath or saliva analysis, careful review of the referenced Code of Federal Regulations, as well as the Commission Rules, will be necessary in order to ensure compliance with the testing procedures used. PRESERVATION OF SPECIMENS AND RECORDS Proposed Rule 9140.70 specifies the length of time the parties must keep either specimens or records associated with drug testing. Laboratories testing the primary specimen of blood or urine with appositive, adulterated or substantive result must retain the specimen for a minimum of three years, and it must be stored in a manner as outlined in the rules and in accordance with the requirements set forth by the Department of Health and Human Services (though not specified, it appears the rule is referring to the Federal agency). An employee, the MRO, or the employer may request, in writing, that the laboratory retain a specimen for an additional period of time not to exceed one year. Split specimens must also be retained in a similar fashion. Laboratories must retain all records pertaining to the testing of each employee specimen for a minimum of two years, though this can be extended through a written request for an additional two years. Employers are required to maintain all collection forms for breath and saliva testing for a minimum of three years, and the employee may request an extension of up to an additional year. Negative testing samples are to be discarded as soon as possible. CONCLUSION Many employers conduct routine drug testing anytime an employee reports a workers’ compensation injury. For those employers, we recommend confirming with your drug testing vendors to confirm whether the procedures to have in place will comply with proposed rules to ensure a timely and effective transition for defending injuries resulting from alcohol or drug intoxication. As it seems that the Commission borrowed from the Code of Federal Regulations when drafting these proposed rules on the process and procedure of specimen collection and drug testing, it is possible that most facilities currently providing specimen collection or drug testing will already be in compliance with these proposed rules. Nevertheless, any facility must be prepared to confirm that it wholly complies with the proposed rules, as even substantial compliance with the rules may still result in a positive drug test result being barred from evidence. This is due to the fact that the rules use mandatory terms like “shall” and “must” throughout. For those employers who do not perform routine drug testing at the time an accident is reported, we would recommend Page 3 of 4
  • 4. For those employers who do not perform routine drug testing at the time an accident is reported, we would recommend identifying a facility or vendor that complies with the proposed rules to which an employee suspected of intoxication can be referred for appropriate sample collection and testing. Even if it is clear by circumstantial evidence that an employee’s accident was caused by his or her intoxication, a failure to properly preserve this evidence through a conforming collection and testing process could result in an inability to deny the claim. By having an appropriate facility identified in advance, the chances of successfully obtaining an admissible test result and defending a claim could increase significantly. Should you have any questions or concerns regarding these proposed comments, please feel free to contact any of the attorneys in our office to discuss them in greater detail. We look forward to an open ongoing dialog with our clients as this new statutory defense in intoxication continues to develop. -- Joseph A. Garofalo Garofalo, Schreiber, Hart & Storm, Chartered 55 West Wacker Drive, 10th Floor Chicago, IL 60601 Office: 312-670-2000 Direct: 312-499-8911 Cell: 312-622-3750 Fax: 312-419-1336 jgarofalo@gshslaw.com www.gshslaw.com Celebrating our 28th year in business This is an advertisement and is being sent to you because of your prior relationship with the firm of Garofalo, Schreiber, Hart & Storm, Chartered. To unscribe click here: Unsubscribe This is an advertisement and is being sent to you because of your prior relationship with the firm of Garofalo, Schreiber, Hart & Storm, Chartered. Page 4 of 4